Center-Authored Papers

Filters: Author is Daly, Mary B  [Clear All Filters]
Journal Article
Bevers TB, Ward JH, Arun BK, Colditz GA, Cowan KH, Daly MB, Garber JE, Gemignani ML, Gradishar WJ, Jordan JA et al..  2015.  Breast Cancer Risk Reduction, Version 2.2015.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(7):880-915. Abstract
Skates SJ, Greene MH, Buys SS, Mai PL, Brown PH, Piedmonte M, Rodriguez GC, Schorge JO, Sherman M, Daly MB et al..  2017.  Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, Li Q, Delgado MK et al..  2016.  Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.. Nature communications. 7:12675. Abstract
Phelan CM, Kuchenbaecker KB, Tyrer JP, Kar SP, Lawrenson K, Winham SJ, Dennis J, Pirie A, Riggan MJ, Chornokur G et al..  2017.  Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.. Nature genetics. Abstract
Couch FJ, Kuchenbaecker KB, Michailidou K, Mendoza-Fandino GA, Nord S, Lilyquist J, Olswold C, Hallberg E, Agata S, Ahsan H et al..  2016.  Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.. Nature communications. 7:11375. Abstract
Zeng C, Guo X, Long J, Kuchenbaecker KB, Droit A, Michailidou K, Ghoussaini M, Kar S, Freeman A, Hopper JL et al..  2016.  Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.. Breast cancer research : BCR. 18(1):64. Abstract
Urban ND, Hawley S, Janes H, Karlan BY, Berg CD, Drescher CW, Manson JE, Palomares MR, Daly MB, Wactawski-Wende J et al..  2015.  Identifying post-menopausal women at elevated risk for epithelial ovarian cancer.. Gynecologic oncology. 139(2):253-260. Abstract
Urban ND, Thorpe J, Karlan BY, McIntosh MW, Palomares MR, Daly MB, Paley P, Drescher CW.  2012.  Interpretation of Single and Serial Measures of HE4 and CA125 in Asymptomatic Women at High Risk for Ovarian Cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(11):2087-94. Abstract
Skates SJ, Mai P, Horick NK, Piedmonte M, Drescher CW, Isaacs C, Armstrong DK, Buys SS, Rodriguez GC, Horowitz IR et al..  2011.  Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status.. Cancer prevention research (Philadelphia, Pa.). 4(9):1401-8. Abstract
Bevers TB, Anderson BO, Bonaccio E, Buys S, Buys S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE et al..  2009.  NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(10):1060-96.
Daly MB, Dresher CW, Yates MS, Jeter JM, Karlan BY, Alberts DS, Lu KH.  2015.  Salpingectomy as a Means to Reduce Ovarian Cancer Risk.. Cancer prevention research (Philadelphia, Pa.). 8(5):342-348. Abstract